Cargando…
Identifying prodromal symptoms at high specificity for Parkinson’s disease
INTRODUCTION: To test drugs with the potential to prevent the onset of Parkinson’s disease (PD), it is key to identify individuals in the general population at high risk of developing PD. This is often difficult because most of the clinical markers are non-specific, common in PD but also common in o...
Autores principales: | Jackson, Holly, Anzures-Cabrera, Judith, Simuni, Tanya, Postuma, Ronald B., Marek, Kenneth, Pagano, Gennaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556459/ https://www.ncbi.nlm.nih.gov/pubmed/37810617 http://dx.doi.org/10.3389/fnagi.2023.1232387 |
Ejemplares similares
-
Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression
por: Jackson, Holly, et al.
Publicado: (2021) -
Evidence of Filamin A loss of solubility at the prodromal stage of neuropathologically-defined Alzheimer’s disease
por: Aumont, Etienne, et al.
Publicado: (2022) -
Intrinsic Brain Activity of Inferior Temporal Region Increased in Prodromal Alzheimer's Disease With Hearing Loss
por: Hong, Luwei, et al.
Publicado: (2022) -
Delirium-Onset of Prodromal Dementia With Lewy Bodies—Putative Brainstem-Related Pathomechanism and Clinical Relevance
por: Hansen, Niels, et al.
Publicado: (2022) -
From Prodromal to Overt Parkinson’s Disease: Towards a New Definition in the Year 2040
por: Berg, Daniela, et al.
Publicado: (2018)